SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter

This publication has 46 references indexed in Scilit:

• CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
  Annual Review of Pharmacology and Toxicology, 2005
• Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family
  Biochemical Journal, 2005
• Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitor
  Cancer Biology & Therapy, 2005
• Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
  Nature Genetics, 2005
• Biological functions of SLC5A8, a candidate tumour suppressor
  Biochemical Society Transactions, 2005
• The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis
  Oncogene, 2004
• Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase Inhibitors
  Clinical Cancer Research, 2004
• Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition
  Biochemical and Biophysical Research Communications, 2004
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate
  Cell Death & Differentiation, 1998